Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac (CVAC) FCF Margin (2020 - 2025)

Historic FCF Margin for CureVac (CVAC) over the last 6 years, with Q3 2025 value amounting to 55.61%.

  • CureVac's FCF Margin fell 167500.0% to 55.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 189.35%, marking a year-over-year decrease of 1988400.0%. This contributed to the annual value of 16.36% for FY2024, which is 6120000.0% up from last year.
  • As of Q3 2025, CureVac's FCF Margin stood at 55.61%, which was down 167500.0% from 3319.92% recorded in Q2 2025.
  • CureVac's 5-year FCF Margin high stood at 1112057.4% for Q4 2021, and its period low was 915112.86% during Q2 2021.
  • In the last 5 years, CureVac's FCF Margin had a median value of 658.69% in 2023 and averaged 30693.93%.
  • Over the last 5 years, CureVac's FCF Margin had its largest YoY gain of 2000000000bps in 2022, and its largest YoY loss of 2000000000bps in 2022.
  • Over the past 5 years, CureVac's FCF Margin (Quarter) stood at 1112057.4% in 2021, then tumbled by -100bps to 1745.58% in 2022, then skyrocketed by 66bps to 593.39% in 2023, then decreased by -8bps to 639.01% in 2024, then skyrocketed by 109bps to 55.61% in 2025.
  • Its FCF Margin stands at 55.61% for Q3 2025, versus 3319.92% for Q2 2025 and 4578.95% for Q1 2025.